Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
SAVA
Cassava Sciences
$3.63
Login to see Cassava Sciences (SAVA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Chart
$2.18 (+66.51%)
$2.16 (+68.06%)
$1.86 (+95.16%)
$29 (-87.48%)
SAVA has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Price under $5
High volatilty
SAVA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
SAVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SAVA Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displaySAVA Earnings
The TTM reflects 12-month period, providing review of SAVA financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is SAVA current stock price?
What are SAVA stock strengths?
What risks are associated with SAVA stock?
When is SAVA next earnings report?
What is SAVA market cap and volume?
What is SAVA's current Stock IQ?
Should I buy SAVA stock right now?
Is SAVA a Strong Buy right now?
What does a 'Strong Buy' rating mean for SAVA?
What does a 'Strong Sell' rating mean for SAVA?
What factors influence SAVA's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
SAVA
Cassava Sciences
Current Price
$3.63
Stock Insights
Strengths
Earnings are forecast to grow
Login to unlock Cassava Sciences (SAVA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$2.18 (+66.51%)
$2.16 (+68.06%)
$1.86 (+95.16%)
$29 (-87.48%)
SAVA Analysts Opinion
SAVA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
SAVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SAVA Street view is bullish and have positive views on the near-term outlook
SAVA has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Price under $5
High volatilty
Average key support and resistance price levels.
Login to displaySAVA Earnings
The TTM data reflects the most recent 12-month period, providing overview of SAVA financial performance.
SAVA Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
SAVA Latest Analysis
Cassava Sciences (SAVA) Stock Is Surging Tuesday: Whats Going On?. ) shares are trading higher Tuesday morning after a Form 4 filing disclosed that CEO average price of $2.25 each.insider purchase injects a dose of confidence following the company’.s decision earlier this year to discontinue the development of its Alzheimer’.s drug simufilam. The halt came after the Phase 3 REFOCUS-ALZ trial failed to meet its primary endpoints for improving cognition and function.Barry called the resu
Tue Sep 23, 2025
Tuesday 9/23 Insider Buying Report: SAVA BCDA. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.At Cassava Sciences (SAVA) a filing with the SEC revealed that on Friday CEO Rich
Tue Sep 23, 2025
Cassava Sciences CEO buys $534K in company stock.
Tue Sep 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SAVA Stock trends
SAVA Stock performance
SAVA Stock analysis
SAVA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings